*NURSING > ESSAY > NR 293 Week 6 Assignment: RUA: Medication Teaching Plan – Nurtec (ODT) | GRADED A (All)
Nurtec ODT (Rimegepant) Chamberlain College of Nursing NR 293 – Pharmacology Rimegepant (Nurtec ODT) is a medication that was first approved by the FDA on February 27, 2020, to be used as a t ... reatment for acute migraines (National Center for Biotechnology Information, 2020). Rimegepant is a calcitonin gene-related peptide receptor antagonist (CGRP), which is also referred to as gepants. Nurtec is the first CGRP to come in an orally disintegrating tablet but has drug interactions with CYP3A4 inhibitors, CYP3A inducers, and transporters. Rimegepant offers migraine relief to an expanded population when compared to triptans. Triptans constrict the blood vessels, which leaves a possibility for coronary artery construction as well. Since Nurtec does not have these properties, patients with hypertension or other heart-related problems are not contraindicated in this medication (Lipton, et al., 2020). Nurtec should be avoided in pregnant, breastfeeding patie [Show More]
Last updated: 3 years ago
Preview 1 out of 3 pages
Buy this document to get the full access instantly
Instant Download Access after purchase
Buy NowInstant download
We Accept:
Can't find what you want? Try our AI powered Search
Connected school, study & course
About the document
Uploaded On
Dec 15, 2022
Number of pages
3
Written in
All
This document has been written for:
Uploaded
Dec 15, 2022
Downloads
0
Views
103
Scholarfriends.com Online Platform by Browsegrades Inc. 651N South Broad St, Middletown DE. United States.
We're available through e-mail, Twitter, and live chat.
FAQ
Questions? Leave a message!
Copyright © Scholarfriends · High quality services·